{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T04:15:23Z","timestamp":1789964123632,"version":"4.0.1"},"reference-count":52,"publisher":"Impact Journals, LLC","issue":"14","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2014,7,30]]},"DOI":"10.18632\/oncotarget.2072","type":"journal-article","created":{"date-parts":[[2015,9,15]],"date-time":"2015-09-15T23:39:14Z","timestamp":1442360354000},"page":"5257-5271","source":"Crossref","is-referenced-by-count":24,"title":["LASP1 is a novel BCR-ABL substrate and a phosphorylation-dependent binding partner of CRKL in chronic myeloid leukemia"],"prefix":"10.18632","volume":"5","author":[{"given":"Jochen J.","family":"Frietsch","sequence":"first","affiliation":[{"name":"Klinik f\u00fcr Innere Medizin II, Abteilung H\u00e4matologie und internistische Onkologie, Universit\u00e4tsklinikum Jena, Jena, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolin","family":"Kastner","sequence":"additional","affiliation":[{"name":"Institute for Clinical Biochemistry and Pathobiochemistry, University Clinic of Wuerzburg, Wuerzburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas G. P.","family":"Grunewald","sequence":"additional","affiliation":[{"name":"INSERM Unit 830, Genetics and Biology of Cancers, Institute Curie Research Center, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hardy","family":"Schweigel","sequence":"additional","affiliation":[{"name":"Department of Clinical Chemistry, University Medical Center Hamburg-Eppendorf, Hamburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Nollau","sequence":"additional","affiliation":[{"name":"Department of Clinical Chemistry, University Medical Center Hamburg-Eppendorf, Hamburg, Germany"},{"name":"Research Institute Children's Cancer Center and Clinic of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janine","family":"Ziermann","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Innere Medizin II, Abteilung H\u00e4matologie und internistische Onkologie, Universit\u00e4tsklinikum Jena, Jena, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim H.","family":"Clement","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Innere Medizin II, Abteilung H\u00e4matologie und internistische Onkologie, Universit\u00e4tsklinikum Jena, Jena, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"La Ros\u00e9e","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Innere Medizin II, Abteilung H\u00e4matologie und internistische Onkologie, Universit\u00e4tsklinikum Jena, Jena, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Hochhaus","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Innere Medizin II, Abteilung H\u00e4matologie und internistische Onkologie, Universit\u00e4tsklinikum Jena, Jena, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elke","family":"Butt","sequence":"additional","affiliation":[{"name":"Institute for Clinical Biochemistry and Pathobiochemistry, University Clinic of Wuerzburg, Wuerzburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2014,6,7]]},"reference":[{"issue":"4","key":"1","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1158\/1078-0432.CCR-10-1613","article-title":"Molecular pathways: BCR-ABL","volume":"18","author":"Saglio","year":"2012","journal-title":"Clin Cancer Res"},{"issue":"8","key":"2","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1182\/blood-2008-03-144790","article-title":"Molecular biology of bcr-abl1-positive chronic myeloid leukemia","volume":"113","author":"Cortes","year":"2009","journal-title":"Blood"},{"issue":"139","key":"3","doi-asserted-by":"crossref","first-page":"re6","DOI":"10.1126\/scisignal.3139re6","article-title":"ABL tyrosine kinases: evolution of function, regulation, and specificity","volume":"3","author":"Colicelli","year":"2010","journal-title":"Sci Signal"},{"issue":"18","key":"4","doi-asserted-by":"crossref","first-page":"15601","DOI":"10.1074\/jbc.M209009200","article-title":"Actin binding of human LIM and SH3 protein is regulated by cGMP- and cAMP-dependent protein kinase phosphorylation on serine 146","volume":"278","author":"Meyer","year":"2003","journal-title":"J Biol Chem"},{"issue":"11","key":"5","doi-asserted-by":"crossref","first-page":"4304","DOI":"10.1182\/blood.V88.11.4304.4304","article-title":"Crkl is constitutively tyrosine phosphorylated in platelets from chronic myelogenous leukemia patients and inducibly phosphorylated in normal platelets stimulated by thrombopoietin","volume":"88","author":"Ikeda","year":"1996","journal-title":"Blood"},{"issue":"1","key":"6","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1172\/JCI35721","article-title":"Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity","volume":"121","author":"Druker","year":"2011","journal-title":"J Clin Invest"},{"issue":"5","key":"7","doi-asserted-by":"crossref","first-page":"765","DOI":"10.3324\/haematol.12186","article-title":"Phospho-CRKL monitoring for the assessment of BCR-ABL activity in imatinib-resistant chronic myeloid leukemia or Ph+ acute lymphoblastic leukemia patients treated with nilotinib","volume":"93","author":"Hochhaus","year":"2008","journal-title":"Haematologica"},{"issue":"3","key":"8","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1083\/jcb.200311045","article-title":"Regulation of cell migration and survival by focal adhesion targeting of Lasp-1","volume":"165","author":"Klemke","year":"2004","journal-title":"J Cell Biol"},{"issue":"6","key":"9","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1093\/bioinformatics\/bts059","article-title":"Predicting relapse prior to transplantation in chronic myeloid leukemia by integrating expert knowledge and expression data","volume":"28","author":"Oehler","year":"2012","journal-title":"Bioinformatics"},{"key":"10","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1476-4598-7-31","article-title":"The LIM and SH3 domain protein family: structural proteins or signal transducers or both?","volume":"7","author":"Butt","year":"2008","journal-title":"Mol Cancer"},{"issue":"13","key":"11","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1016\/j.febslet.2006.04.082","article-title":"Short-term retention of actin filament binding proteins on lamellipodial actin bundles","volume":"580","author":"Miyamoto","year":"2006","journal-title":"FEBS Lett"},{"key":"12","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/1471-2407-7-198","article-title":"Nuclear localization and cytosolic overexpression of LASP-1 correlates with tumor size and nodal-positivity of human breast carcinoma","volume":"7","author":"Honig","year":"2007","journal-title":"BMC Cancer"},{"issue":"7","key":"13","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.yexcr.2005.12.016","article-title":"Silencing of LASP-1 influences zyxin localization, inhibits proliferation and reduces migration in breast cancer cells","volume":"312","author":"Butt","year":"2006","journal-title":"Exp Cell Res"},{"issue":"3","key":"14","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1177\/030089160909500315","article-title":"Genomic markers for ovarian cancer at chromosomes 1, 8 and 17 revealed by array CGH analysis","volume":"95","author":"Theillet","year":"2009","journal-title":"Tumori"},{"issue":"20","key":"15","doi-asserted-by":"crossref","first-page":"8003","DOI":"10.1158\/0008-5472.CAN-10-0592","article-title":"Role of LIM and SH3 protein 1 (LASP1) in the metastatic dissemination of medulloblastoma","volume":"70","author":"Reifenberger","year":"2010","journal-title":"Cancer Res"},{"issue":"9","key":"16","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1136\/gut.2009.202739","article-title":"Promotion of colorectal cancer growth and metastasis by the LIM and SH3 domain protein 1","volume":"59","author":"Ding","year":"2010","journal-title":"Gut"},{"key":"17","article-title":"Loss of tumor suppressor mir-203 mediates overexpression of LIM and SH3 Protein 1 (LASP1) in high-risk prostate cancer thereby increasing cell proliferation and migration","author":"Butt","year":"2014","journal-title":"Oncotarget"},{"issue":"11","key":"18","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1038\/sj.bjc.6605685","article-title":"Nuclear localisation of LASP-1 correlates with poor long-term survival in female breast cancer","volume":"102","author":"Butt","year":"2010","journal-title":"Br J Cancer"},{"issue":"2","key":"19","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/sj.bjc.6603545","article-title":"Overexpression of LASP-1 mediates migration and proliferation of human ovarian cancer cells and influences zyxin localisation","volume":"96","author":"Butt","year":"2007","journal-title":"Br J Cancer"},{"issue":"2","key":"20","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s10048-006-0032-6","article-title":"Gene expression analyses reveal molecular relationships among 20 regions of the human CNS","volume":"7","author":"Zlotnik","year":"2006","journal-title":"Neurogenetics"},{"issue":"50","key":"21","doi-asserted-by":"crossref","first-page":"20012","DOI":"10.1073\/pnas.1116110108","article-title":"Human bone marrow hematopoietic stem cells are increased in frequency and myeloid-biased with age","volume":"108","author":"Weissman","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"22","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.cell.2004.06.028","article-title":"Single cell profiling of potentiated phospho-protein networks in cancer cells","volume":"118","author":"Nolan","year":"2004","journal-title":"Cell"},{"issue":"6","key":"23","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1038\/sj.leu.2404189","article-title":"BCR-ABL activity and its response to drugs can be determined in CD34+ CML stem cells by CrkL phosphorylation status using flow cytometry","volume":"20","author":"Holyoake","year":"2006","journal-title":"Leukemia"},{"issue":"16","key":"24","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1038\/onc.2012.216","article-title":"Nuclear import of LASP-1 is regulated by phosphorylation and dynamic protein-protein interactions","volume":"32","author":"Butt","year":"2013","journal-title":"Oncogene"},{"issue":"191","key":"25","first-page":"RE12","article-title":"SH2 and PTB domains in tyrosine kinase signaling","volume":"2003","author":"Lemmon","year":"2003","journal-title":"Sci STKE"},{"issue":"6","key":"26","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.molcel.2007.05.031","article-title":"High-throughput phosphotyrosine profiling using SH2 domains","volume":"26","author":"Mayer","year":"2007","journal-title":"Mol Cell"},{"issue":"3","key":"27","first-page":"520","article-title":"Integrin-dependent translocation of LASP-1 to the cytoskeleton of activated platelets correlates with LASP-1 phosphorylation at tyrosine 171 by Src-kinase","volume":"102","author":"Butt","year":"2009","journal-title":"Thromb Haemost"},{"issue":"2","key":"28","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1128\/MCB.12.2.609","article-title":"Point mutations in the abl SH2 domain coordinately impair phosphotyrosine binding in vitro and transforming activity in vivo","volume":"12","author":"Baltimore","year":"1992","journal-title":"Mol Cell Biol"},{"issue":"8","key":"29","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/nrc3317","article-title":"Pushing the limits of targeted therapy in chronic myeloid leukaemia","volume":"12","author":"Deininger","year":"2012","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"30","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.beha.2009.04.005","article-title":"Prognostic factors in chronic myeloid leukaemia","volume":"22","author":"Cervantes","year":"2009","journal-title":"Best Pract Res Clin Haematol"},{"issue":"2","key":"31","first-page":"353","article-title":"Active (p)CrkL is overexpressed in human malignancies: potential role as a surrogate parameter for therapeutic tyrosine kinase inhibition","volume":"15","author":"Czerwenka","year":"2006","journal-title":"Oncol Rep"},{"issue":"53","key":"32","doi-asserted-by":"crossref","first-page":"8196","DOI":"10.1038\/sj.onc.1205975","article-title":"Novel genes regulated by Sonic Hedgehog in pluripotent mesenchymal cells","volume":"21","author":"Wainwright","year":"2002","journal-title":"Oncogene"},{"issue":"1","key":"33","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.canlet.2012.08.006","article-title":"Selective elimination of leukemia stem cells: hitting a moving target","volume":"338","author":"Jamieson","year":"2013","journal-title":"Cancer Lett"},{"issue":"5","key":"34","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/leu.2011.360","article-title":"Inhibition of CXCR4 in CML cells disrupts their interaction with the bone marrow microenvironment and sensitizes them to nilotinib","volume":"26","author":"Griffin","year":"2012","journal-title":"Leukemia"},{"issue":"4","key":"35","doi-asserted-by":"crossref","first-page":"e10050","DOI":"10.1371\/journal.pone.0010050","article-title":"LIM and SH3 protein-1 modulates CXCR2-mediated cell migration","volume":"5","author":"Richmond","year":"2010","journal-title":"PLoS One"},{"issue":"6","key":"36","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/nchembio.954","article-title":"Domain organization differences explain Bcr-Abl's preference for CrkL over CrkII","volume":"8","author":"Kalodimos","year":"2012","journal-title":"Nat Chem Biol"},{"key":"37","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1177\/1947601912459951","article-title":"Models of crk adaptor proteins in cancer","volume":"3","author":"Park","year":"2012","journal-title":"Genes Cancer"},{"issue":"8","key":"38","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1128\/MCB.23.8.2883-2892.2003","article-title":"Translocation of CrkL to focal adhesions mediates integrin-induced migration downstream of Src family kinases","volume":"23","author":"Imamoto","year":"2003","journal-title":"Mol Cell Biol"},{"issue":"4","key":"39","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.bbrc.2005.06.030","article-title":"Interaction of Bcr\/Abl with C3G, an exchange factor for the small GTPase Rap1, through the adapter protein Crkl","volume":"333","author":"Heisterkamp","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"40","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1007\/s13277-013-0851-7","article-title":"Overexpression of CRKL correlates with malignant cell proliferation in breast cancer","volume":"34","author":"Li","year":"2013","journal-title":"Tumour Biol"},{"issue":"3","key":"41","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1007\/s12031-013-0096-3","article-title":"CrkL efficiently mediates cell proliferation, migration, and invasion induced by TGF-beta pathway in glioblastoma","volume":"51","author":"Yao","year":"2013","journal-title":"J Mol Neurosci"},{"issue":"3","key":"42","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1182\/blood-2006-10-050799","article-title":"Conventional Western blotting techniques will not reliably quantify p210BCR-ABL1 levels in CML mononuclear cells","volume":"109","author":"Gordon","year":"2007","journal-title":"Blood"},{"issue":"2","key":"43","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/biostatistics\/4.2.249","article-title":"Exploration, normalization, and summaries of high density oligonucleotide array probe level data","volume":"4","author":"Speed","year":"2003","journal-title":"Biostatistics"},{"issue":"20","key":"44","doi-asserted-by":"crossref","first-page":"e175","DOI":"10.1093\/nar\/gni179","article-title":"Evolving gene\/transcript definitions significantly alter the interpretation of GeneChip data","volume":"33","author":"Meng","year":"2005","journal-title":"Nucleic Acids Res"},{"issue":"8","key":"45","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/boc.201300011","article-title":"Lysophosphatidic acid (LPA) signalling in cell migration and cancer invasion: a focussed review and analysis of LPA receptor gene expression on the basis of more than 1700 cancer microarrays","volume":"105","author":"Grunewald","year":"2013","journal-title":"Biol Cell"},{"issue":"1","key":"46","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1093\/biostatistics\/kxj037","article-title":"Adjusting batch effects in microarray expression data using empirical Bayes methods","volume":"8","author":"Rabinovic","year":"2007","journal-title":"Biostatistics"},{"issue":"2","key":"47","doi-asserted-by":"crossref","first-page":"e17238","DOI":"10.1371\/journal.pone.0017238","article-title":"Removing batch effects in analysis of expression microarray data: an evaluation of six batch adjustment methods","volume":"6","author":"Liu","year":"2011","journal-title":"PLoS One"},{"issue":"1","key":"48","first-page":"186","article-title":"An optimized multiplex polymerase chain reaction (PCR) for detection of BCR-ABL fusion mRNAs in haematological disorders","volume":"8","author":"Goldman","year":"1994","journal-title":"Leukemia"},{"issue":"11","key":"49","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1038\/sj.leu.2401566","article-title":"Accurate and rapid analysis of residual disease in patients with CML using specific fluorescent hybridization probes for real time quantitative RT-PCR","volume":"13","author":"Hochhaus","year":"1999","journal-title":"Leukemia"},{"issue":"3","key":"50","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1093\/annonc\/mdj106","article-title":"Prediction of response to imatinib by prospective quantitation of BCR-ABL transcript in late chronic phase chronic myeloid leukemia patients","volume":"17","author":"Baccarani","year":"2006","journal-title":"Ann Oncol"},{"issue":"11","key":"51","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1038\/sj.leu.2404388","article-title":"Rationale for the recommendations for harmonizing current methodology for detecting BCR-ABL transcripts in patients with chronic myeloid leukaemia","volume":"20","author":"Hughes","year":"2006","journal-title":"Leukemia"},{"key":"52","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/978-1-60327-834-8_11","article-title":"Profiling the tyrosine phosphorylation state using SH2 domains","volume":"527","author":"Nollau","year":"2009","journal-title":"Methods in molecular biology"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.2072","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T19:53:37Z","timestamp":1589399617000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.2072"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,7]]},"references-count":52,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2014,7,30]]}},"alternative-id":["2072","24913448"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.2072","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,7]]}}}